Skip to content
Stock screener

BEAT HeartBeam, Inc. stock chart & analysis

Conviction 36HealthcareScan · Thu, Nov 19, 2026

HeartBeam, Inc. (BEAT) closed at $0.3082 (-9.46%) on Nov 19, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 34, RS Rating 5, -92.3% from its 52-week high, -87.2% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.

BEAT$0.3082-9.46%
ResistanceSupportVol 14Insider buy
Loading chart…

Why BEAT moved

From the StockSetups movers recaps that covered BEAT, newest first. A recap states what was known that day.

  • Close+54.0%

    HeartBeam, Inc. (BEAT) surged +54.0% to close at $0.67 on volume of 156,264,569 shares — nearly 19× its 20-day average of 8,288,978. The stock gapped up +72.3% at the open before trimming gains slightly into the close.

    Top Stock Movers Oct 5, 2026: MI, VEEA, BEAT →
  • Premarket+88.2%

    HeartBeam received an FDA Breakthrough Device Designation for its heart attack assessment technology, according to Yahoo Finance and Stock Titan this morning.

    Premarket Movers Oct 5, 2026: MI, BEAT, ALEC →
HeartBeam, Inc.Surgical & Medical Instruments & Apparatuswww.heartbeam.com ↗
Price0.3082
Change-9.46%
Gap+0.82%
Rel volume0.15×
Avg volume1.26M
Avg $ vol569.74K
SMA 200.4125
SMA 500.4228
SMA 2000.7706
Price vs 50-27.10%
Price vs 200-60.01%
MA stackbearish
50/200 cross—
Supertrenddown · 0.4414
RSI (14)34
MACD hist-0.01
MACD cross—
Stoch %K / %D3 / 5
ADX (14)18
+DI / −DI20 / 35
RSI divergence—
MACD divergence—
ATR %13.81%
ADR %10.51%
52w high4.00
52w low0.3000
From 52w high-92.30%
Above 52w low+2.73%
New 52w highNo
SqueezeOff
Bollinger width59.82%
%B0.08
Donchian pos2.98%
Donchian high0.5748
Donchian low0.3000
AVWAP (52w high)1.06
vs AVWAP high-70.98%
AVWAP (52w low)0.3171
vs AVWAP low-2.82%
OBV trendUp
Chaikin MF (20)0.09
Today vs 20d0.15×
Avg vol (14d)882.32K
Avg vol (20d)1.26M
Avg $ vol (20d)569.74K
Market cap19.51M
RS Rating5 / 99
RS 3m (vs SPY)-31.01%
RS 6m (vs SPY)-62.90%
RS line new highNo
Trend template0/8
Technical rank11.4
1 week-23.66%
1 month-24.28%
3 months-37.52%
6 months-66.52%
1 year-81.87%
YTD-87.16%
P/E-0.93
P/B3.00
P/S—
P/FCF-1.34
EPS-0.6200
Div yield—
ROE-322.61%
ROA-266.96%
Debt/Eq—
Current4.64
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-8.06%
Price target—
Target upside—
Analyst rating—
Institutional12.82%
Ent. value13.45M
Revenue—
Net income-3.01M
Gross profit—
Free cash flow-14.59M
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNasdaq
Shares out55.51M
Employees17
ListedThu, Nov 11, 2021
Free float30.08M
Float %75.0%
Short interest—
Days to cover—
Short volume49.4%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction36 / 100
Pattern quality—
Tech rank11.4 / 100
Group rank—
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.7623
Support0.3691
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

BEAT technical analysis

Trend

BEAT is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 27.1% below the 50-day ($0.4228) and 60.0% below the 200-day ($0.7706). ADX(14) at 18 points to a weak trend — more range than direction. It meets 0 of 8 trend-template criteria.

Momentum

RSI(14) is 34, in the bearish half of its range. The MACD histogram is negative. Its RS Rating of 5 puts its weighted 12-month performance ahead of about 5% of the US market.

Volume and volatility

Volume on the latest session ran 0.1× its 20-day average. It trades about $569,744 a day on average. ATR(14) is $0.0426, 13.8% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (0.09) shows accumulation.

Key levels

The chart pattern's support is $0.3691 and its resistance $0.7623. The 52-week range is $0.3000 to $4.00; price is 92.3% below the high and 2.7% above the low. The VWAP anchored at the 52-week high is $1.06, above price.

Performance

BEAT returned -23.7% (1 week), -24.3% (1 month), -37.5% (3 months), -66.5% (6 months), -81.9% (1 year), -87.2% (year to date).

About HeartBeam, Inc.

HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.

Surgical & Medical Instruments & Apparatus · Listed 2021 · 17 employees

Insider activity

SEC Form 4 transactions in BEAT

InsiderSideShares
Ortigas-Wedekind Marga
Director · Restricted Stock Units · 2026-10-02
Grant93.75K
de Urioste George
Director · Stock Option (Right to Buy) · 2026-10-02
Grant93.75K
JAFF MICHAEL R
Director · Restricted Stock Units · 2026-10-02
Grant37.5K
Elfrink Willem
Director · Restricted Stock Units · 2026-10-02
Grant93.75K
Elfrink Willem
Director · Stock Option (right to buy) · 2026-10-02
Grant93.75K
Ferrari Richard
Director · Restricted Stock Units · 2026-10-02
Grant125K
Ferrari Richard
Director · Restricted Stock Units · 2026-10-02
Grant90.63K
Ferrari Richard
Director · Stock Option (Right to Buy) · 2026-10-02
Grant125K
de Urioste George
Director · Restricted Stock Units · 2026-10-02
Grant93.75K
Nelson Kenneth Warwick III
Director · Restricted Stock Units · 2026-10-02
Grant93.75K

SEC filings

EDGAR filings in BEAT · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.